Evidence map›Paper›PMID 27006387›Full record

ArticleBlood2016

A novel DFP tripeptide motif interacts with the coagulation factor XI apple 2 domain.

Szu S Wong, Søren Østergaard, Gareth Hall, Chan Li, Philip M Williams, Henning Stennicke, Jonas Emsley

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Szu S WongCentre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; and Novo Nordisk, Måløv, Denmark.
Søren ØstergaardNovo Nordisk, Måløv, Denmark.
Gareth HallCentre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; and.
Chan LiCentre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; and.
Philip M WilliamsCentre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; and.
Henning StennickeNovo Nordisk, Måløv, Denmark.
Jonas EmsleyCentre for Biomolecular Sciences, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom; and.ORCID 0000-0002-8949-8030
University of Nottingham · GBNovo Nordisk (Denmark) · DK

Funding

British Heart Foundation RG/07/002/23132British Heart Foundation RG/12/9/29775
6 · The paper itself

Abstract

Factor XI (FXI) is the zymogen of FXIa, which cleaves FIX in the intrinsic pathway of coagulation. FXI is known to exist as a dimer and interacts with multiple proteins via its 4 apple domains in the "saucer section" of the enzyme; however, to date, no complex crystal structure has been described. To investigate protein interactions of FXI, a large random peptide library consisting of 10(6) to 10(7) peptides was screened for FXI binding, which identified a series of FXI binding motifs containing the signature Asp-Phe-Pro (DFP) tripeptide. Motifs containing this core tripeptide were found in diverse proteins, including the known ligand high-molecular-weight kininogen (HK), as well as the extracellular matrix proteins laminin and collagen V. To define the binding site on FXI, we determined the crystal structure of FXI in complex with the HK-derived peptide NPISDFPDT. This revealed the location of the DFP peptide bound to the FXI apple 2 domain, and central to the interaction, the DFP phenylalanine side-chain inserts into a major hydrophobic pocket in the apple 2 domain and the isoleucine occupies a flanking minor pocket. Two further structures of FXI in complex with the laminin-derived peptide EFPDFP and a DFP peptide from the random screen demonstrated binding in the same pocket, although in a slightly different conformation, thus revealing some flexibility in the molecular interactions of the FXI apple 2 domain.

Indexed as

Amino Acid SequenceAnimalsAsparagineBinding SitesCHO CellsCricetinaeCricetulusCrystallography, X-RayFactor XIHumansModels, MolecularPeptide FragmentsPhenylalanineProlineProtein BindingProtein DomainsAsparagineFactor XIPeptide FragmentsPhenylalanineProline

Identifiers

PMID27006387
PMCPMC4991086
OpenAlexW2332512334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.